RxDoctor Payments Data

Samuel Hensley, MD

Anatomic Pathology & Clinical Pathology · Flowood, MSNPI 1801884234

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 42.2% of the total. Reporting peaked in 2021 at $98 and has fallen 79.0% since, to $21 in 2025.

$290in general payments, 2019–2025

Across 19 payments — averaging $15.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$122
  • Takeda Pharmaceuticals U.S.A., Inc.$73
  • Regeneron Healthcare Solutions, Inc.$56
  • Intercept Pharmaceuticals, Inc.$14
  • Merck$13
  • Shire North American Group Inc$12

What the payments were for

  • Food & beverage$290100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$290 in reported general payments places this provider in the 70th percentile of 69 anatomic pathology & clinical pathology providers in Mississippi.

See all anatomic pathology & clinical pathology providers in Mississippi

Medicare billing

Part B allowed, 2024
$316,367
Medicare patients
2,011
Services billed
5,293

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Flowood

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →